← Leaderboards
Caroline Ellen Sloan
Duke University
$547,033
Attributed
$547,033
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $186.9K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$547,033 · 1
By mechanism
K23$547,033 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Susan Davis Emmett$5,103,176
- Cindy Amundsen$14,610,494
- John Eric Jelovsek$1,277,289
- Kenneth A Dodge$42,207,577
- Nicole Depasquale$709,926
Others in their field
Other Rising Stars on “Acceptability And Feasibility”
- Schenita D. Randolph · Duke University$3,870,187
- Saeed Ahmed · Baylor College Of Medicine$3,372,206
- Tanya L Zakrison · University Of Chicago$3,254,872
- Czarina Navos Behrends · Weill Medical Coll Of Cornell Univ$3,156,884
- Keith Copelin Ferdinand · Tulane University Of Louisiana$2,797,027
- Heather Zierhut · University Of Minnesota$2,600,212
Research focus
Acceptability And FeasibilityAdherenceAdoptedAffectAgedAssessment ToolAwardBarrier To CareCareerCaringCessation Of LifeCharacteristicsChronicClinics And HospitalsColoradoComorbidityComplexCostCost EstimateCost-Sharing InsuranceDecision MakingDedicationsDesignAcademic Medical Centers
Grant awards (3)
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools$181,733
K23 · FY2025 · AG · contact PI
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools$178,387
K23 · FY2024 · AG · contact PI
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools$186,913
K23 · FY2023 · AG · contact PI